The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry

The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry

Background: The latest guidelines recommend the use of proton pump inhibitors (PPIs) to minimize gastrointestinal bleeding (GIB) in patients receiving dual antiplatelet therapy (DAPT), even though this co-administration may increase the risk of ischemia due to drug interactions. We have noticed that...

Full description

Bibliographic Details
Main Authors: Wence Shi, Lin Ni, Jingang Yang, Xiaoxue Fan, Mei Yu, Hongmei Yang, Mengyue Yu, Yuejin Yang, China Acute Myocardial Infarction (CAMI) Registry study group
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
proton pump inhibitors
acute myocardial infarction
gastrointestinal bleeding (GIB)
co-medication
lower risk
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.685072/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.685072/full

Similar Items